CD4 and breast cancer: In another study by Wesolowski et al., the authors concluded that neo-ACT influences the immune microenvironment by downregulating CD4+ and upregulating CD8+ cells, which leads to a reduction in the number of TILs and CD8+ T cells in breast cancer samples 45.